Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

CRB Bio II and ADE Capital Sodical Commits €3M Seed Investment Round

Published: Monday, July 08, 2013
Last Updated: Monday, July 08, 2013
Bookmark and Share
Raman Health Technologies develops a new non invasive diagnostic technology platform for multiple diseases based on Raman laser spectroscopy.

CRB Bio II and ADE Capital Sodical have committed a €3M seed investment round in Raman Health Technologies, a new start up company developing a new non invasive diagnostic technology platform based on Raman laser and Infrared spectroscopy. Its first indication will be for the early diagnosis of Alzheimer disease in a blood sample.

Raman Health, based at the Boecillo Technology Park, is a spin-off of the University of Valladolid Fernando Rull, Professor of Crystallography and Mineralogy of the University of Valladolid is one of the key persons in this project.

This financing round will allow the company to achieve its strategic objectives, namely the establishment of a new expanded lab facility to foster the development of the methodology for the detection of spectroscopic biomarkers and the development of a robust diagnostic platform.

Laser to detect Alzheimer
The platform being developed by Raman Health Technologies will be used for the diagnosis of different diseases in a blood sample.

In the case of Alzheimer disease, it avoids the need of invasive techniques, like the lumbar punction to obtain cerebrospinal fluid and will provide a significant improvement in costs and logistics compared to Imaging Technologies (NMR or PET).

Additionally, based on its capability to identify different biological substances, the spectroscopy of Raman Health Technologies can provide simultaneously information of several biomarkers with just one spectroscopic reading.

When compared to other diagnostic technologies, Raman-Laser based spectroscopy is faster, less invasive and cheaper. Additionally no reagents are needed. Raman Health Technologies can change the diagnosis of complex diseases like Alzheimer.

CRB Bio II third investment
This transaction is the third investment made by CRB Bio II, one of the largest specialized Life Science Funds in Spain, after those made in Oncovision and Amadix, for a total aggregated investment in excess of €3,5M.

“This last investment underscores our commitment to invest in disruptive technologies at early stage of development in life sciences. In the case of Raman Health Technologies, this is a very cost-effective technology, with a terrific potential and multiple application areas.” says Pablo Cabello, CSO of CRB Inverbío.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More Than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
JPK NanoWizard® Applied to a Wide Range of Research
The NanoWizard® AFM from JPK is applied for interdisciplinary research at the University of South Australia for applications including smart wound healing and how plants can protect themselves from toxins.
Mutations in DNA-Repair Genes Found in Advanced Prostate Cancers
New findings indicate that nearly 12% of male advanced prostate cancer sufferers have inherited mutation in DNA-repair genes.
Protein Boosts Rice Yield by 54%
Over-expression of a natural protein in rice plants led to a 54% increase in crop yield and 40% increase in nitrogen-use efficiency.
Ice Bucket Challenge Instrumental in Gene Discovery
Donations from the ALS Ice Bucket Chellenge allowed for the largest-ever study of inherited ALS, which identified a new ALS gene.
Genetic Variability in Cell Bank Lots
Researchers working with cancer cells from the same cell bank acquired at the same time, found that the cells were genetically different.
Triple-Action Therapy Patch Shows Promise
Patch that delivers drug, gene, and light-based therapy to tumor sites shows promising results in mice.
Soil Nitrogen Age Important for Precision Agriculture
Calculating the age of nitrogen in corn and soybean fields could lead to improved fertilizer application techniques.
Targeting Autoimmunity
Researchers have developed a strategy to treat a rare autoimmune disease which could lead to treatments of other autoimmune diseases.
Molecule May Affect Gaucher, Parkinson's Disease
Research has identified a molecule that restores activity of a dysfunctional enzyme linked to Gaucher and Parkinson's disease.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!